Evidence map›Paper›PMID 35807263›Full record

ArticleMolecules (Basel, Switzerland)2022

Regioselective One-Pot Synthesis, Biological Activity and Molecular Docking Studies of Novel Conjugates

Asma Nsira, Hasan Mtiraoui, Sami Chniti, Hanan Al-Ghulikah, Rafik Gharbi, Moncef Msaddek

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Asma NsiraLaboratory of Heterocyclic Chemistry Natural Products and Reactivity/CHPNR, Department of Chemistry, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.
Hasan MtiraouiLaboratory of Heterocyclic Chemistry Natural Products and Reactivity/CHPNR, Department of Chemistry, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.
Sami ChnitiLaboratory of Heterocyclic Chemistry Natural Products and Reactivity/CHPNR, Department of Chemistry, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.ORCID 0000-0003-2125-0220
Hanan Al-GhulikahDepartment of Chemistry, College of Sciences, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.
Rafik GharbiLaboratory of Applied Chemistry and Environment, Department of Chemistry, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.
Moncef MsaddekLaboratory of Heterocyclic Chemistry Natural Products and Reactivity/CHPNR, Department of Chemistry, Faculty of Science of Monastir, University of Monastir, Monastir 5000, Tunisia.

Funding

Princess Nourah bint Abdulrahman University PNURSP2022R95
6 · The paper itself

Abstract

Novel 1,2,3-triazolo-linked-1,5-benzodiazepinones were designed and synthesized via a Cu(I)-catalyzed 1,3-dipolar alkyne-azide coupling reaction (CuAAC). The chemical structures of these compounds were confirmed by

Indexed as

Antifungal AgentsCopperAlkynesAnti-Bacterial AgentsAzidesBenzodiazepinesCatalysisClick ChemistryMolecular Docking SimulationMolecular Structure1,5-benzodiazepin-2-oneAlkynesAnti-Bacterial AgentsAntifungal AgentsAzidesBenzodiazepinesCopper1,5-benzodiazepin-2-onesantibacterial activityantifungal activityazidesclick chemistryCuAACdockingN-triazolo-benzodiazepinones

Identifiers

PMID35807263
PMCPMC9268147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.